What is the recommended management for a patient with Pelvic Organ Prolapse Quantification (POP‑Q) stage I?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of POP-Q Stage I Pelvic Organ Prolapse

Conservative management with pelvic floor muscle training (PFMT) and lifestyle modifications is the recommended first-line approach for POP-Q stage I prolapse, as surgery is only indicated for stage 2 or greater prolapse when symptoms are disabling. 1, 2

Clinical Context and Staging Considerations

  • Stage I prolapse by POP-Q definition (descent to ≥1 cm above the hymen) may not represent clinically significant pathology, as research suggests that anterior and posterior vaginal wall descent of <-1 cm should probably be regarded as normal. 3

  • Women with stage I prolapse have similar symptom frequencies as those with stage 2-4 prolapse, indicating that symptom burden rather than anatomical stage should guide treatment decisions. 4

  • The current POP-Q staging system requires revision for stage I prolapse, as the definition may not accurately reflect clinically relevant disease. 5, 3

First-Line Conservative Management

Pelvic Floor Muscle Training

  • PFMT is strongly recommended as first-line therapy for stage I prolapse, particularly when associated with urinary incontinence symptoms. 1

  • For stress urinary incontinence associated with prolapse, PFMT alone is the preferred initial treatment. 1

  • For urgency urinary incontinence, bladder training programs are strongly recommended, and for mixed incontinence, combine PFMT with bladder training. 1

Lifestyle Modifications

  • Weight loss and regular exercise are strongly recommended for obese women with prolapse, as these modifiable risk factors contribute to prolapse progression. 1

  • Address chronic straining, constipation, and heavy lifting, as these are established risk factors for prolapse development and progression. 6

Pessary Management

  • Pessaries are recommended as first-line conservative treatment and can be offered in combination with PFMT. 2, 7

  • Pessaries can result in symptomatic improvement in most patients with POP, making them appropriate for nearly all patients not desiring surgery. 7

When Surgery Is NOT Indicated

  • Surgery should NOT be offered for stage I prolapse, as surgical intervention is only indicated when prolapse is stage 2 or greater on examination, symptoms are disabling and related to the prolapse, and conservative options have failed to meet patient expectations. 1, 2

  • In asymptomatic stage I prolapse, observation is the appropriate management strategy. 6

Symptom Assessment Framework

  • Query specific symptoms including: sensation of vaginal bulging or protrusion, pelvic pressure, urinary incontinence, difficulty emptying bladder, frequent urination, urgency, incomplete voiding, need for splinting/digital maneuvers to void, bowel dysfunction, and sexual dysfunction. 8, 6

  • Document the impact of symptoms on daily life and quality of life, as this guides treatment intensity rather than anatomical stage alone. 2

Pharmacologic Considerations

  • When bladder training fails for urgency incontinence, anticholinergic agents or β-sympathomimetic drugs are indicated, with drug choice based on tolerability, side effects, ease of use, and cost. 1

  • Systemic pharmacologic therapy for stress urinary incontinence is strongly discouraged. 1

Critical Clinical Pitfalls

  • Do not perform surgery based solely on anatomical stage I findings without disabling symptoms, as the threshold for surgical intervention requires stage 2 or greater prolapse. 1, 2

  • Do not skip conservative management, as PFMT and pessaries should be offered to most patients before considering surgical options. 2, 7

  • Recognize that stage I prolapse may represent normal anatomical variation, particularly for anterior and posterior compartments with descent <-1 cm. 3

References

Guideline

Evaluation and Management of Sudden‑Onset Stage 2 Uterine Prolapse in Perimenopausal Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Management of female pelvic organ prolapse-Summary of the 2021 HAS guidelines.

Journal of gynecology obstetrics and human reproduction, 2023

Research

POP-Q stage I prolapse: is it time to alter our terminology?

International urogynecology journal, 2014

Research

Evaluation and Management of Pelvic Organ Prolapse.

Mayo Clinic proceedings, 2021

Research

Nonsurgical management of pelvic organ prolapse.

Obstetrics and gynecology, 2012

Guideline

Cystocele Diagnosis and Imaging

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.